Although leptin at physiological levels may exert therapeutic effects, pathophysiological amounts of leptin, mimicking diabetes or obesity, exhibit potent proatherogenic properties. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.